Australian Patient Becomes First to Survive Over 100 Days With Artificial Titanium Heart

The BiVACOR Total Artificial Heart, designed as a bridge to transplants, marks a major milestone in addressing the global heart donor shortage.

An Australian man lived for 105 days with the BiVACOR Total Artificial Heart before receiving a donor heart transplant in March 2025.
The BiVACOR TAH, made of titanium, uses a magnetically levitated spinning disc to pump blood, reducing wear and mechanical failure.
The device is currently in clinical trials and serves as a temporary solution for patients awaiting heart transplants.
This marks the sixth successful implantation globally and the first case where a patient was discharged from the hospital with the device.
Researchers are exploring the potential for the BiVACOR TAH to serve as a permanent heart replacement for patients ineligible for transplants.